Trexquant Investment LP Takeda Pharmaceutical CO LTD Transaction History

Trexquant Investment LP

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$15.28 - $16.48 $308,167 - $332,368	-20,168 Reduced 12.04%	147,340 $2.43 Million
Q4 2022 Feb 13, 2023	BUY	$12.42 - $15.62 $1.91 Million - $2.41 Million	154,122 Added 1151.37%	167,508 $2.61 Million
Q3 2022 Nov 14, 2022	SELL	$12.8 - $28.65 $433,753 - $970,862	-33,887 Reduced 71.68%	13,386 $174,000
Q2 2022 Aug 11, 2022	BUY	$13.12 - $15.03 $620,221 - $710,513	47,273 New	47,273 $664,000
Q1 2022 May 13, 2022	SELL	$13.54 - $15.35 $453,928 - $514,608	-33,525 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$13.17 - $16.4 $441,524 - $549,810	33,525 New	33,525 $457,000
Q3 2020 Nov 06, 2020	SELL	$17.1 - $19.19 $257,799 - $289,308	-15,076 Closed	0 $0
Q2 2020 Aug 07, 2020	BUY	$14.59 - $19.5 $219,958 - $293,982	15,076 New	15,076 $270,000
Q1 2020 May 08, 2020	SELL	$13.02 - $20.31 $146,383 - $228,345	-11,243 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$16.88 - $20.83 $9,942 - $12,268	589 Added 5.53%	11,243 $222,000
Q3 2019 Nov 08, 2019	BUY	$16.15 - $17.99 $172,062 - $191,665	10,654 New	10,654 $183,000

320

70.4M

939K

233K

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $43.1B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

Stay updated on Trexquant Investment LP with notifications on news.